DentalEZ Identafi

MALVERN, Pennsylvania--DentalEZ Group, a supplier of products and services for dental health professionals worldwide, has unveiled the recent purchase of Identafi,.To read more about DentalEZ, go to DentalEZ.Identafi is an oral cancer screening device used for the detection of oral mucosal abnormalities. The unveiling took place at the California Dental Association 2011 Spring Scientific Session.Now marketed under the StarDental brand, Identafi detects biochemical and morphological changes in the cells of the mouth, throat, tongue, and tonsils that may potentially lead to oral cancer. The small, cordless, handheld device uses a three-wavelength optical illumination and visualization system that allows dental professionals to identify oral mucosal abnormalities that may not be visible to the naked eye. Identafi is intended for use by dentists, hygienists, and oral surgeons. The handheld device uses white, patented 405-nm violet, and green-amber wavelengths of light to monitor biochemical changes with fluorescence while morphological changes are monitored with reflectance. The combined system of fluorescence and reflectance uses the body’s natural tissue properties as an adjunctive tool for oral mucosal examination. The combination of all three multi-spectral wavelengths can provide the clinician with more visual information, improved results over direct visual exam alone, and increased confidence for recommending subsequent biopsies. Using Identafi in the highly concentrated “White Light” mode, the dental professional can first perform a conventional tissue examination of the entire oral cavity. The dental professional then switches to the patented 405-nanometer “Fluorescent Violet Light” to help identify any areas of abnormal tissue growth. The violet light enhances normal tissue’s natural fluorescence; however, suspicious tissue will appear dark in color due to its loss of fluorescence. When suspect abnormalities are present, the instrument is switched to the unique “Green-Amber Reflectance Light,” which enhances normal tissue’s reflectance properties so the clinician may directly observe the difference between normal and abnormal tissue’s vasculature. Studies indicate that abnormal tissue has a diffuse vasculature, whereas normal tissue vasculature is clearly defined. Additional features and benefits of the Identafi oral screening device include:• Patented 405-nm violet wavelength offers differentiation of suspicious lesions• Small, compact size coupled with an angled examination mirror allows easy inspection of hard-to-reach areas• Space-saving design fits any treatment room• No need for messy, bad-tasting dyes/solutions• Enhances perception of the dental practice as the “highest standard of care”• Dental reimbursement code can provide ROI for itself in as few as eight weeks“DentalEZ will offer a number of continuing education courses, educational seminars, and online resources geared toward educating dental professionals on the specific use of the Identafi technology and oral cancer in general, which is so important to the successful application of this product,” sai Rick Gross, senior product manager. “Because the signs and symptoms of oral cancer often cannot be seen by the naked eye, Identafi technology enables dental professionals on the front line of oral cancer detection to do just that--identify changes in the mouth that may be a sign of something more serious.” Identafi will be sold by DentalEZ Group’s national organization of sales representatives through its existing distributor network. For more information, call 866-DTE-INFO or visit www.identafi.net. To comment on this product, go to community.pennwelldentalgroup.com/.